These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 38066611)

  • 1. Molecular subtypes of breast cancer predicting clinical benefits of radiotherapy after breast-conserving surgery: a propensity-score-matched cohort study.
    Hung SK; Yang HJ; Lee MS; Liu DW; Chen LC; Chew CH; Lin CH; Lee CH; Li SC; Hong CL; Yu CC; Yu BH; Hsu FC; Chiou WY; Lin HY
    Breast Cancer Res; 2023 Dec; 25(1):149. PubMed ID: 38066611
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 21-Gene recurrence score predictive for prognostic benefit of radiotherapy in patients age ≥ 70 with T1N0 ER/PR + HER2- breast cancer treated with breast conserving surgery and endocrine therapy.
    Chevli N; Haque W; Tran KT; Farach AM; Schwartz MR; Hatch SS; Butler EB; Teh BS
    Radiother Oncol; 2022 Sep; 174():37-43. PubMed ID: 35772577
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-Term Outcomes of Immunohistochemically Defined Subtypes of Breast Cancer Less Than or Equal to 2 cm After Breast-Conserving Surgery.
    Pata G; Guaineri A; Bianchi A; Amoroso V; Pasinetti N; Pasini M
    J Surg Res; 2019 Apr; 236():288-299. PubMed ID: 30694768
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of 21-Gene Recurrence Score in Predicting Prognostic Benefit of Radiation Therapy After Breast-Conserving Surgery for T1N0 Breast Cancer.
    Chevli N; Haque W; Tran KT; Farach AM; Schwartz MR; Hatch SS; Butler EB; Teh BS
    Pract Radiat Oncol; 2023; 13(3):e230-e238. PubMed ID: 36038115
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Radiotherapy is recommended for hormone receptor-negative older breast cancer patients after breast conserving surgery.
    Liu Y; Li J; Li H; Zhang G; Li C; Wei C; Zeng J
    Sci Rep; 2024 Sep; 14(1):21355. PubMed ID: 39266585
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Clinical features and prognosis of patients with first-episode liver metastasis of different molecular subtypes of breast cancer].
    Wu SY; Tan Y; Guan YS
    Zhonghua Gan Zang Bing Za Zhi; 2016 Jun; 24(6):422-8. PubMed ID: 27465945
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Breast-conserving surgery without axillary lymph node surgery or radiotherapy is safe for HER2-positive and triple negative breast cancer patients over 70 years of age.
    Zhong Y; Xu Y; Zhou Y; Mao F; Lin Y; Guan J; Shen S; Pan B; Wang C; Peng L; Huang X; Li Y; Wang X; Sun Q
    Breast Cancer Res Treat; 2020 Jul; 182(1):117-126. PubMed ID: 32430680
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Loco-regional recurrence trend and prognosis in young women with breast cancer according to molecular subtypes: analysis of 1099 cases.
    Li Y; Lu S; Zhang Y; Wang S; Liu H
    World J Surg Oncol; 2021 Apr; 19(1):113. PubMed ID: 33849563
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hormone receptors and HER-2 status as surrogates for breast cancer molecular subtypes prognosticate for disease control in node negative Asian patients treated with breast conservation therapy.
    Wong FY; Chin FK; Lee KA; Soong YL; Chua ET
    Ann Acad Med Singap; 2011 Feb; 40(2):90-6. PubMed ID: 21468463
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of molecular subtype on 1325 early-stage breast cancer patients homogeneously treated with hypofractionated radiotherapy without boost: Should the indications for radiotherapy be more personalized?
    Fodor A; Brombin C; Mangili P; Borroni F; Pasetti M; Tummineri R; Zerbetto F; Longobardi B; Perna L; Dell'Oca I; Deantoni CL; Deli AM; Chiara A; Broggi S; Castriconi R; Esposito PG; Slim N; Passoni P; Baroni S; Villa SL; Rancoita PMV; Fiorino C; Del Vecchio A; Bianchini G; Gentilini OD; Di Serio MS; Di Muzio NG
    Breast; 2021 Feb; 55():45-54. PubMed ID: 33326894
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Outcome in breast molecular subtypes according to nodal status and surgical procedures.
    Mazouni C; Rimareix F; Mathieu MC; Uzan C; Bourgier C; André F; Delaloge S; Garbay JR
    Am J Surg; 2013 Jun; 205(6):662-7. PubMed ID: 23312273
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Breast conserving surgery (BCS) with adjuvant radiation therapy showed improved prognosis compared with mastectomy for early staged triple negative breast cancer patients Running title: BCS had better prognosis than mastectomy for early TNBC patients.
    Wang SE; Sun YD; Zhao SJ; Wei F; Yang G
    Math Biosci Eng; 2019 Sep; 17(1):92-104. PubMed ID: 31731341
    [No Abstract]   [Full Text] [Related]  

  • 13. 21-gene recurrence score predictive of the benefit of postoperative radiotherapy after breast-conserving surgery for elderly patients with T1N0 and luminal breast cancer.
    Wang RJ; Liu HY; Guo LF; Yu D; Wu SG
    Breast Cancer; 2024 Nov; 31(6):1156-1166. PubMed ID: 39300035
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Breast cancer subtype approximated by estrogen receptor, progesterone receptor, and HER-2 is associated with local and distant recurrence after breast-conserving therapy.
    Nguyen PL; Taghian AG; Katz MS; Niemierko A; Abi Raad RF; Boon WL; Bellon JR; Wong JS; Smith BL; Harris JR
    J Clin Oncol; 2008 May; 26(14):2373-8. PubMed ID: 18413639
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of Treatment Outcomes With Breast-conserving Surgery Plus Radiotherapy Versus Mastectomy for Patients With Stage I Breast Cancer: A Propensity Score-matched Analysis.
    Wang J; Wang S; Tang Y; Jing H; Sun G; Jin J; Liu Y; Song Y; Wang W; Fang H; Ren H; Yu Z; Li Y
    Clin Breast Cancer; 2018 Oct; 18(5):e975-e984. PubMed ID: 30054238
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Young age is associated with ipsilateral breast tumor recurrence after breast conserving surgery and radiation therapy in patients with HER2-positive/ER-negative subtype.
    Kim HJ; Han W; Yi OV; Shin HC; Ahn SK; Koh BS; Moon HG; You JH; Son BH; Ahn SH; Noh DY
    Breast Cancer Res Treat; 2011 Nov; 130(2):499-505. PubMed ID: 21853352
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Survival After Breast-Conserving Surgery Compared with that After Mastectomy in Breast Cancer Patients Receiving Neoadjuvant Chemotherapy.
    Gwark S; Kim HJ; Kim J; Chung IY; Kim HJ; Ko BS; Lee JW; Son BH; Ahn SH; Lee SB
    Ann Surg Oncol; 2023 May; 30(5):2845-2853. PubMed ID: 36577865
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of Elective Nodal Irradiation in Patients With ypN0 After Neoadjuvant Chemotherapy Followed by Breast-Conserving Surgery (KROG 16-16).
    Cho WK; Park W; Choi DH; Kim YB; Kim JH; Kim SS; Kim K; Kim JH; Ahn SJ; Lee SY; Lee J; Kim SW; Kwon J; Ahn KJ
    Clin Breast Cancer; 2019 Feb; 19(1):78-86. PubMed ID: 30241965
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Outcomes According to Breast Cancer Subtype in Patients Treated With Accelerated Partial Breast Irradiation.
    Wilkinson JB; Shah C; Amin M; Nadeau L; Shaitelman SF; Chen PY; Grills IS; Martinez AA; Mitchell CK; Wallace MF; Vicini FA
    Clin Breast Cancer; 2017 Feb; 17(1):55-60. PubMed ID: 27666436
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of omission of adjuvant radiotherapy after neoadjuvant chemotherapy and breast conserving surgery with a pathologic complete response.
    Mandish SF; Gaskins JT; Yusuf MB; Amer YM; Eldredge-Hindy H
    Acta Oncol; 2020 Oct; 59(10):1210-1217. PubMed ID: 32716227
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.